AEHR Q1 2026 Earnings Call Summary | Stock Taper
Logo
AEHR

AEHR — Aehr Test Systems

NASDAQ


Q1 2026 Earnings Call Summary

October 6, 2025

AEHR Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics:

  • Revenue: $11 million for Q1 2026, up from $13.1 million in Q1 2025, but lower than last year's strong consumables revenue.
  • Gross Margin: Non-GAAP gross margin decreased to 37.5% from 54.7% year-over-year, attributed to lower sales volume and a less favorable product mix.
  • Operating Expenses: Increased by 8% to $5.9 million, primarily due to higher R&D expenses.
  • Net Income: Reported net income of $2.2 million or $0.07 per diluted share.
  • Backlog: Ended Q1 with a backlog of $15.5 million, with an effective backlog totaling $17.5 million.
  • Cash Position: $24.7 million in cash and equivalents, down from $26.5 million in Q4 2025.

2. Strategic Updates and Business Highlights:

  • Focus on semiconductor test and burn-in markets, particularly driven by AI and data center infrastructure growth.
  • Continued momentum in AI processor testing, with significant orders from a leading hyperscaler.
  • Enhancements to the Sonoma system, including increased power capacity and automation, received positive customer feedback.
  • Successful collaboration with a major OSAT for wafer-level burn-in solutions, showcasing Aehr's unique capabilities.
  • Expansion into silicon photonics, hard disk drives, and gallium nitride markets, with ongoing customer engagements and upgrades.

3. Forward Guidance and Outlook:

  • Management remains optimistic about broad-based growth opportunities across AI and other markets, despite not reinstating formal guidance due to ongoing tariff-related uncertainties.
  • Anticipation of increased order volumes, particularly in the second half of fiscal 2026, as customer demand for AI processing solutions grows.
  • Continued focus on enhancing manufacturing capabilities and capacity to support customer needs.

4. Bad News, Challenges, or Points of Concern:

  • Significant decline in consumables revenue, which dropped from $12.1 million (92% of total revenue) in Q1 2025 to $2.6 million (24% of total revenue) in Q1 2026.
  • Non-GAAP gross margin decline raises concerns about product mix and pricing pressures.
  • Ongoing tariff-related uncertainties may impact future guidance and operational planning.
  • The company is cautious about potential delays in customer orders and the timing of new product introductions.

5. Notable Q&A Insights:

  • Management indicated that while they are seeing increased customer engagement, the timing of material orders remains uncertain, with expectations leaning towards the second half of fiscal 2026.
  • Discussions revealed that many customers are currently using inefficient system-level testing instead of production burn-in, highlighting the need for improved reliability testing.
  • The competitive landscape is shifting, with a strong emphasis on reliability and burn-in testing, particularly for AI and advanced semiconductor devices.
  • Management emphasized the importance of wafer-level burn-in as a cost-effective solution, with the potential for significant market growth driven by reliability needs.
  • The Q&A highlighted ongoing customer interest in both package and wafer-level solutions, with a clear indication of Aehr's unique position in the market.